Travera Inc

Travera Inc, based in Cambridge, MA, is a pioneering company that offers a Rapid Therapy Selection Test for cancer patients. Using innovative technology developed at MIT, their test evaluates a wide range of FDA-approved drug options to determine the most effective treatment for each patient's unique cancer. With an impressive two-day turnaround time, Travera provides patients and their physicians with valuable information to make informed decisions about their cancer care.

With a team of research and clinical experts from top institutions, Travera is dedicated to bringing hope and improved clinical outcomes to cancer patients worldwide. Their test, available through an Early Access Program, allows physicians to define a panel of up to 20 FDA-approved drugs to be tested based on the patient's cancer type and stage. While the test is not currently covered by insurance, Travera offers financial assistance options to make it accessible to as many patients as possible.

Generated from the website